Tag: melanoma
New Study Demonstrates Integrin Activation Can Bring the Heat to Cold...
HOUSTON, May 18, 2022 (GLOBE NEWSWIRE) -- 7 Hills Pharma LLC ("7 Hills" or "7HP"), together with The University of Texas...
Iovance Biotherapeutics Announces 33-Month Follow Up Data for Lifileucel in Advanced...
Median Duration of Response (DOR) Not Reached at 33.1 Months of Median Study Follow Up in Cohort 2 in C-144-01 Study ...
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018...
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have...
Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath® Melanoma,...
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision...
Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma...
Median Duration of Response Not Reached at 28.1 Months of Median Study Follow Up in Cohort 2 of C-144-01 Study 36.4% Overall Response...
Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab...
EXTON, Pa., March 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA; the “Company”) today is announcing that ILLUMINATE-301, the...